Prescription Software for Doctors in India: 2026 Landscape

India's prescription software market in 2026 is not one category. It's three distinct things wearing the same label. There are full clinic-management suites that include a prescription module. There are dictation tools that transcribe what you say into a drug list. And there are ambient scribes that draft the prescription from the conversation while also checking it for safety before you sign. Buying the wrong category means paying for features you don't need while the actual problem, handwritten prescriptions that are slow, illegible, and unchecked, stays unsolved.

Key takeaways

• India's "prescription software" market splits into three types: full EMR with Rx modules, dictation tools, and ambient scribes. They solve different problems.
• No Indian tool currently sends prescriptions to a pharmacy; digital Rx here means a typed or printed prescription the patient takes to a chemist.
• A deterministic Rx safety screener, checking interactions, renal flags, and pregnancy contraindications, is a distinct layer from AI drafting. Most tools don't have one.
• DPDP Act 2023 makes prescription data a Data Fiduciary obligation. Ask every vendor whether audio is stored and where prescription text lives.
• AI Scribe by Patient Square drafts the Rx during the visit and screens it before sign: ₹1,199/month ex-GST on launch annual billing (Solo), 7-day trial, no card.

Sources: Irving et al., BMJ Open 2017; AI Scribe by Patient Square product facts.

What "prescription software" actually means in India

The label covers a wide range. At the lowest end, it is a fillable template on a tablet: you type the drug and dose and print it. One step up is a dictation tool that transcribes your voice into a prescription. A level above that is an ambient scribe that drafts the prescription, mid-consult, from the conversation you are already having, then screens the draft for safety before you review it.

The terminology also drifts. "E-prescription," "digital prescription," "Rx software," and "online prescription software" are used interchangeably by vendors even when the products are doing fundamentally different things. What they all share is that no Indian tool in 2026 routes the prescription electronically to a pharmacy. That is an important distinction from how e-prescribing works in the US or UK. Here, digital prescription software generates a typed or printed document the patient carries to the chemist. The value is legibility and time, not transmission.

This matters practically. If you are comparing products and a vendor says "e-prescribing," ask what that means. In the Indian context it almost certainly means "we generate a digital Rx" not "we send it to a pharmacy." If they do claim pharmacy transmission, get the specifics.

The three types of tools and when each fits

Full clinic-management system with Rx module

Tools like HealthPlix and Practo Ray include prescription management as one feature inside a larger clinic suite. You get billing, pharmacy inventory, appointments, and the prescription in one place. The prescription module is form-driven: you search for a drug, fill the fields, and print.

This is the right choice when your practice needs billing and dispensing to live in the same system as the clinical record. HealthPlix, which publishes its prices first-party at ₹11,999 per year (Pro) and ₹17,999 per year (Elite), includes drug-drug interaction (DDI) alerts as a named feature. That is the only tool in the full-EMR category that makes a first-party safety claim worth noting. Practo Ray does not publish pricing (sales-gated); third-party estimates run roughly ₹1,000–6,000 per doctor per month.

Where these tools fall short for documentation: you do the typing. The prescription module does not listen to your consult and draft from it. In a 2-minute OPD, every second spent on a keyboard matters.

Dictation and voice-to-text tools

Augnito Spectra is the main standalone dictation product in India. You dictate your prescription; the tool transcribes and structures it. It is useful if you are faster speaking than typing, particularly for doctors comfortable dictating in a specific clinical format. Augnito does not publish a website price (sales-gated); the App Store India listing shows in-app purchases at ₹1,199, ₹3,299, and ₹11,900 with billing periods not labeled. It offers a 7-day trial.

The limitation is that dictation is transcription, not drafting. You say the drug name; it writes what you said. There is no ambient listening that extracts a drug plan from a natural conversation, no safety screen running on the output, and no SOAP note wrapped around it.

Ambient scribes with integrated Rx drafting

This is where the category gets interesting for a solo GP managing a heavy daily schedule. An ambient scribe listens during the consultation and, when the visit ends, hands back a full SOAP note, ICD-10 suggestions, and a prescription draft. You did not dictate; you just had the consult the way you always do. EkaScribe (by eka.care) and AI Scribe by Patient Square both sit in this category.

EkaScribe is ₹1,499 per doctor per month (Pro), with a free tier capped at 5 consultations per day. It names 20+ Indian languages for input, including Hindi, Bengali, Tamil, and Telugu, and integrates with the eka.care platform, which has live ABDM/ABHA workflows. On prescription safety, EkaScribe does not headline a specific drug safety screener on its pricing page.

AI Scribe by Patient Square is an ambient AI medical scribe that listens during the visit and hands back a structured SOAP note, ICD-10 suggestions, and a prescription draft, ready to review and sign about two minutes after the visit.

How the tool handles your two-minute consult

Think through the actual mechanics of a busy Tuesday. You see 40 patients. The consult itself is maybe 90 to 120 seconds. The handwriting, or the typing, happens on top of that. In a clinic running that density, any step that interrupts the consult to demand keyboard attention is a step that compounds into 40 extra minutes by evening.

An ambient scribe removes the keyboard from the loop. You speak with the patient; the draft appears after they leave. You review it, make any adjustments, sign it. The prescription text was drafted from what you actually said in the visit, not from a form you filled.

That architecture also has a data-handling implication under the DPDP Act 2023. Prescription data is personal health data under DPDP. If a tool stores audio of your consultation on a remote server, that audio contains the prescription discussion plus everything else the patient said. Processing it with consent-first, purpose-limited handling is now a legal obligation, not a product nicety. Ask every vendor: is audio retained, and if so, where and for how long?

Where the safety question lives

This is the part of the prescription-software conversation that most vendor pages skip.

A language model can draft a prescription. It can also draft one with a dangerous drug combination, an inappropriate renal dose, or a drug contraindicated in pregnancy. The AI does not inherently know your patient's creatinine or whether she is 8 weeks pregnant. Without a separate, deterministic safety check running on the draft, the system is assuming you will catch the problem. At the end of a 40-patient day, that assumption is not a safe one.

A deterministic safety screener is a different thing from the language model. It runs fixed clinical rules, drug-interaction databases, renal-dosing thresholds, pregnancy contraindication tables, against the draft. The same drug combination triggers the same alert every time, not sometimes. And if the screener finds a problem, it hard-blocks the prescription rather than letting you sign past it silently. You can override, but only explicitly, with an attestation that gets recorded.

That is the design that makes Rx drafting actually safe, and it is the claim worth asking about directly when you are evaluating tools. Not "does it use AI?" but "what runs on the draft before I sign it, and when?"

Comparison: what each type actually does

The table is built from first-party vendor pages as of May 2026. HealthPlix and EkaScribe figures come from their published pricing. Augnito prices come from the App Store India listing. Practo Ray publishes no first-party price and is omitted.

When should you pick the full EMR over a scribe? When billing, pharmacy, inventory, or live ABDM linking is the actual problem. A scribe that drafts a better prescription does not fix a broken billing workflow. Those are different fires. When your evenings are going to handwriting, not collections, the documentation layer is the right lever.

Our Rx draft: what it does and what it deliberately doesn't

We think the most useful thing a prescription tool can do is draft from the consult and then screen the draft, so the doctor is checking a safety-screened starting point rather than generating one from scratch. That is the job AI Scribe by Patient Square is built for.

You run the visit the way you normally would. The scribe listens. After the patient leaves, you get a SOAP note with ICD-10 suggestions and a prescription draft. The Rx safety screener runs before you see it. Drug interaction, renal-dosing concern, pregnancy flag. It re-runs when you hit sign. If the draft has a problem, you get a hard stop, not a suggestion. You can override it, but only explicitly, with an attestation that gets logged.

What it does not do is transmit the prescription anywhere. You review it, adjust it, and sign it. How it reaches the chemist is your call, paper or print. We draft; we do not dispense.

Visit audio is processed in memory and discarded when the note is created. No recording on a server. The prescription text stays in the note record, which belongs to your practice: you can export or delete any visit at any time.

On pricing: Solo is ₹1,199 per clinician per month on launch annual billing, ex-GST. Add 18% GST and the invoice is about ₹1,415. Group (2+ clinicians) is ₹999 ex-GST. No feature gating between the tiers; the Rx screener, the ICD-10 suggestions, everything runs the same on both. There is a 7-day full-featured trial with no card required.

On ABDM: we have it on the roadmap; it is not shipped. We won't mark a roadmap feature as available. If live ABDM linking is something your practice needs today, EkaScribe's broader eka.care platform has it, and the best AI medical scribes comparison for India gives a fuller picture of where each tool sits.

The next step is to run the scribe on an actual clinic day before you decide. See the Rx safety screener explained if you want the technical detail on how the deterministic check works. If you want to see where your own consults land as notes and prescriptions, book a short demo or start the trial from our pricing page.

A prescription tool you trust is one you have watched handle your patients, your drug choices, your accents. No scorecard replaces that Tuesday.